logo
After 4 bird flu deaths, Gorakhpur and Kanpur zoos step up monitoring and test staff

After 4 bird flu deaths, Gorakhpur and Kanpur zoos step up monitoring and test staff

Indian Express18-05-2025

After a report from a Bhopal-based laboratory confirmed the presence of a bird flu strain in four animals that died at the Gorakhpur and Kanpur zoos in Uttar Pradesh, the zoo authorities have started testing their staff as a precaution. Each zoo employs over 100 staff members.
Samples of animals housed in the two zoos are also being sent for testing to the National Institute of High-Security Animal Diseases in Bhopal, Madhya Pradesh, and the Indian Veterinary Research Institute, Bareilly. Special attention is being given to animals showing abnormal behaviour, such as loss of appetite, and their samples are being collected for analysis. Regular sanitisation is being carried out at both zoos and zoo staff have been instructed to strictly adhere to all precautionary measures.
This month, a tigress, a wolf and a leopard died at the Gorakhpur zoo and the tigress and the leopard tested positive for bird flu. At the Kanpur zoo, samples of a tigress and a peacock found dead last week were sent to the laboratory for examination and both tested positive.
Since the report was received, regular sanitisation has been carried out at the Gorakhpur zoo, officially known as Shaheed Ashfaqullah Khan Zoological Park, and the Kanpur Zoological Park.
Shraddha Yadav, director of the Kanpur zoo, stated, 'Testing of the entire zoo staff is underway.'
A team led by the chief medical officer of Kanpur has arrived to conduct the tests. The Kanpur zoo employs around 106 staff members. Yadav also mentioned that random samples from animals housed in the zoo were being sent for examination.
Vikas Yadav, director of the Gorakhpur zoo, said that all 105 staff members were examined and all were found negative. He added that a few samples of animals from the zoo had been sent for testing.
The poultry farms in Kanpur and Gorakhpur are also being sanitised and samples are being sent for examination.
Directions have also been issued to restrict the entry of outsiders to all poultry farms in the districts. The workers of poultry farms were advised to enter the farms only after getting properly sanitised besides adopting other measures.
Last week, after the tigress that died recently at the Gorakhpur zoo tested positive for a strain of bird flu, the government took several precautionary measures, including a week-long closure of three zoological parks and the Lion Safari in Etawah for visitors, along with continuous surveillance of animals housed in these facilities.
Aditi Sharma, director of the Lucknow zoo, said that since no animals had died at the zoo recently, no samples had been sent for testing. She added that if any animals showed abnormal behaviour, appropriate action would be taken.
Anil Patel, director of the Lion Safari in Etawah, said the animals were being monitored closely, but none had shown any abnormal signs thus far. 'No samples have been sent for testing from here,' he added.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UAE Health Ministry ends birth and death certification service: What you need to know
UAE Health Ministry ends birth and death certification service: What you need to know

Time of India

timean hour ago

  • Time of India

UAE Health Ministry ends birth and death certification service: What you need to know

In a sweeping administrative change, the UAE Ministry of Health and Prevention (MoHAP) has officially ended its role in issuing birth and death certificates. These vital registration services are now handled by Emirates Health Services (EHS) in the northern emirates, while Dubai and Abu Dhabi continue under their respective local health authorities. Tired of too many ads? go ad free now The transition was made quietly, with MoHAP removing all related service options from its website and discontinuing its WhatsApp-based application system. Residents are now required to navigate a decentralised process based on their emirate of residence. What Has Changed? MoHAP has withdrawn from issuing birth and death certificates. Emirates Health Services (EHS) is now responsible in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah. Dubai Health Authority (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. Certificates issued by EHS, DHA, or DoH are fully equivalent to those formerly issued by MoHAP. BIRTH CERTIFICATES: How It Works Now Who Can Apply? Parents (of any nationality), legal guardians, or authorised delegates. Where to Apply? Via the EHS website (requires UAE Pass) Through the Mabrouk Ma Yak platform (for Emiratis only) At EHS public health centres or hospitals Documents Needed: Valid Emirates ID and passport for both parents Hospital-issued, certified birth notification Electronic civil record Marriage certificate or notarised parentage document For UAE citizens with births abroad: Return tickets ID and passports of both parents Attested marriage certificate For complex cases (e.g., prison births): Court-issued documents Letters from correctional facilities or social services Birth notifications Fees & Turnaround (Converted to INR) Birth Certificate in Arabic: AED 65 (~₹1,470) English Copy (optional): AED 65 (~₹1,470) Time to Issue: 1 working day DEATH CERTIFICATES: Procedure and Conditions Who Can Apply? Immediate family members or legally authorised persons. Where to Apply? Through the EHS online portal At a designated public health centre or hospital Documents Required: Emirates ID or passport of the deceased No Objection Certificate (NOC) from Ministry of Interior Official death report In suspicious or unknown-cause deaths: Forensic report Name consistency across all documents is mandatory International Use: Certificates must be attested by the UAE Ministry of Foreign Affairs and International Cooperation and the embassy of the relevant foreign country. Fees & Timelines (Converted to INR) Death Certificate in Arabic: AED 65 (~₹1,470) English Copy (optional): AED 65 (~₹1,470) Time to Issue: 5 minutes for e-certificates Physical copy available upon in-person visit Service Hours Monday to Thursday: 7:30 AM to 3:30 PM Friday: 7:30 AM to 12:00 PM Why the Change Matters The UAE is continuing its trend of devolving administrative authority to regional bodies, particularly for citizen services. Emirates Health Services already manages most public healthcare in the northern emirates, making it a natural successor to MoHAP in handling life-event documentation. The Bottom Line The next time you need a birth or death certificate in the UAE, MoHAP is no longer your go-to authority. Depending on where you live, you'll be interacting with EHS, DHA, or DoH—with new procedures, slightly altered fees, and a greater push toward digital verification. While the transition might be procedural, it signals a larger shift in how civil documentation is administered across the UAE—more digital, more localised, and firmly tied to regional health systems. (Exchange rate used: 1 AED = ₹22.60)

KKR, TPG eye Relisys Medical Devices in early-stage buyout talks
KKR, TPG eye Relisys Medical Devices in early-stage buyout talks

Mint

timean hour ago

  • Mint

KKR, TPG eye Relisys Medical Devices in early-stage buyout talks

MUMBAI : Relisys Medical Devices is in early-stage discussions with global private equity firms KKR and TPG for a potential ₹1,200–1,300 crore investment, with the transaction likely to offer a full or partial exit to existing investor Siguler Guff, two people familiar with the matter told Mint. 'While TPG is evaluating the company to strengthen its portfolio, KKR is in discussions with the medical devices maker to build out its med-tech platform under which it acquired Healthium Medtech last year from Apax Funds," one of the people cited above said. TPG, too, may look at developing a med-tech platform of its own, the person added. A majority of the proceeds from the transaction, if it materialises, will likely be secondary in nature, enabling Siguler Guff to partially or fully exit. A smaller primary infusion may also be included to fund Relisys's expansion plans, said the second person. Both private equity firms are expected to seek a controlling stake in the Hyderabad-based medical devices maker. In secondary deals, existing shareholders sell their stakes to other investors and the company doesn't receive any new capital. Such shares are usually traded at a discount to primary equity. While KKR declined to comment, TPG, Siguler Guff, Healthium, and Relisys did not respond to Mint's mails sent on Sunday. Also read: Zydus bets big on vaccines and medtech In February, VCCircle had reported that o3 Capital, a mid-market investment bank, was advising Relisys in its search for potential buyers. The report also noted that existing investor Siguler Guff was exploring a full or partial exit, alongside the company's founders, in a transaction then estimated to be valued at $50–70 million ( ₹435–610 crore). Company background Founded in 1997 by technocrats and clinicians, Relisys Medical Devices manufactures cardiovascular products like drug-eluting stents, balloon catheters, diagnostic catheters, and transcatheter heart valves. It also acquired Multimedics in 2018 to expand its stent-making capabilities globally. In FY24, the company reported revenue of ₹169.4 crore, up slightly from ₹162.7 crore a year earlier. Net profit rose marginally to ₹36.3 crore, according to data from Tracxn. The bustling deal activity in the sector also underscores the growing investor appetite for med-tech companies in India. Some notable transactions include Meril Life Sciences $210 million funding from Warburg Pincus which also invested about $300 million in Appasamy Associates. SMT raised $150 million from Samara Capital while Translumina raised around $90 million from Everstone Capital. Also read: Health ministry to set up a panel to review medical device-related adverse events Sector outlook India's $12 billion med-tech market is projected to hit $50 billion by 2030, according to EY. Despite $3.8 billion in exports last fiscal, the country is still heavily import-dependent, with imports at $8.2 billion, making up 80–85% of domestic consumption. Growth is expected to be driven by rising income levels, wider insurance coverage, medical tourism, and rapid healthcare infrastructure expansion in Tier 2 and 3 cities. EY noted that global MNCs are increasingly choosing India for R&D, manufacturing, and global capability centers (GCCs)—further strengthening the ecosystem. Also read: India eyes global pharma dominance with a ₹5,000 crore revitalisation plan

Apollo Hospitals plans to sell maternity care arm
Apollo Hospitals plans to sell maternity care arm

Time of India

time10 hours ago

  • Time of India

Apollo Hospitals plans to sell maternity care arm

Apollo Hospitals Enterprises, India's largest private hospital chain, plans to sell Apollo Cradle and Children's Hospital (ACCHL), a chain of maternity and infant care hospitals , multiple people familiar with the development said. Apollo has hired Allegro Capital to find a buyer for the asset, which is likely to be valued at ₹1,000-1,200 crore, they said. The sale process has been launched and the banker has sounded out to a bunch of leading private equity funds . An email sent to Apollo Hospitals spokesperson for comments on Friday did not elicit any responses till the press time on Sunday. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Schlechter Stuhlgang? Diese Methode funktioniert wie "auf Knopfdruck" Darmschutz Ratgeber Undo ACCHL, a subsidiary of Apollo Specialty Hospitals, has about 363 beds under 13 hospitals across cities like Delhi, Bengaluru, Chennai, Hyderabad, Amritsar, Gurugram, Noida and Ghaziabad. For the year ended March 2024, ACCHL recorded a net loss of ₹17 lakh, according to Apollo's annual report. The mother and child care market in India is estimated at about ₹30,000 crore a year and is expected to grow 15% compounded annually over the next few years. The market is currently dominated by a handful of private hospitals such as Apollo Cradle, Hyderabad-based Rainbow Children's Medicare , and Bengaluru-based chains Motherhood, Cloudnine Hospitals and Kangaroo Care. Live Events British International Investment Plc-backed Rainbow got listed in 2022 and has a market cap of ₹14,260 crore as of Friday. Motherhood is backed by TPG Growth and Singapore's GIC, while Cloudnine is backed by domestic PE fund True North, TPG NewQuest, Temasek and Peak XV. Indira IVF, the country's largest fertility clinics chain owned by EQT Partners, entered into maternity and childcare with the launch of MatCare Maternity & Child Hospital in March. Private equity firm SeaLink Capital Partners and the promoters of Surya Children's Medicare are, meanwhile, looking to sell a majority stake in western India's largest children's hospital chain. A deal is expected to value the company at ₹1,000-1,200 crore, ET reported last year. As of March 31, 2024, Apollo Hospitals had a capacity of 10,134 beds across 73 hospitals in India and overseas. Of these, 8,710 beds are located in 45 owned hospitals, 271 beds in 11 daycare/short surgical stay centres, and 790 beds in six hospitals under management through operations and management contracts.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store